Testosterone replacement therapy reliably suppresses sperm production. This is a predictable pharmacological consequence, not a rare side effect. When exogenous testosterone is detected by the hypothalamus and pituitary, these glands reduce their output of gonadotropin-releasing hormone (GnRH), luteinizing hormone (LH), and follicle-stimulating hormone (FSH). Without FSH, the Sertoli cells in the testes that support sperm development stop functioning normally, and spermatogenesis falls, sometimes to zero.

This matters most for men who have not yet had children or who may want to in the future. For these men, the choice of treatment approach for low testosterone is not just about symptom relief, it determines whether they preserve or sacrifice fertility.

How Severe Is the Suppression?

The suppression of sperm production from TRT is substantial and consistent across delivery methods. A 2009 study in the Journal of Clinical Endocrinology and Metabolism found that injectable testosterone enanthate reduced sperm concentration to below 1 million per mL in approximately 70-90% of users within six months. Normal sperm concentration is 16 million per mL or above per WHO criteria.

The degree of suppression varies between individuals. Most men on TRT become severely oligospermic (very low sperm count) or azoospermic (no sperm). A small subset maintains some sperm production even on TRT, likely due to individual variation in HPG axis sensitivity to negative feedback.

Injectable testosterone tends to cause more complete suppression than topical gels because injections produce higher peak testosterone levels, generating a stronger inhibitory signal to the pituitary.

Is Fertility Suppression Reversible?

Sperm production typically recovers after TRT is discontinued, but recovery is slow and not guaranteed for all men.

A 2020 systematic review in Andrology found that median time to recovery of normal sperm concentrations after stopping exogenous testosterone was approximately 3-6 months, with 90% of men recovering within 12 months. A small percentage, approximately 2-3% in this analysis, did not recover normal sperm counts within the observation period.

Factors that predict slower or incomplete recovery:

  • Longer duration of TRT use (years rather than months)
  • Older age
  • Preexisting fertility issues before starting TRT
  • Higher doses of testosterone used

Men who plan to discontinue TRT and attempt conception should discuss expected recovery timelines with a urologist or reproductive endocrinologist before stopping treatment.

Options for Preserving Fertility While Treating Low Testosterone

Sperm banking before starting TRT: Cryopreserving sperm before initiating testosterone replacement is the most reliable way to preserve fertility options. Once TRT begins, the window for reliable sperm collection closes quickly. Any man who has not yet had children and is considering TRT should have this conversation explicitly before starting.

HCG (human chorionic gonadotropin): HCG mimics LH and directly stimulates Leydig cell testosterone production and Sertoli cell function in the testes. Used alongside TRT, it maintains testicular volume and sperm production in many men. Some men use HCG alone as a testosterone-raising strategy that avoids HPG axis suppression. A 2005 study in Fertility and Sterility found that men on TRT who added HCG maintained sperm concentrations compared to those on TRT alone who suppressed to azoospermia.

Clomiphene citrate: As discussed in Clomiphene for Low Testosterone: An Alternative to TRT, clomiphene stimulates the HPG axis rather than replacing testosterone. Because it works through the natural signaling pathway, it preserves FSH secretion and thus sperm production. For men with secondary hypogonadism who want to maintain fertility, clomiphene is often the first-line recommendation.

FSH supplementation: Recombinant FSH injections can stimulate sperm production in men on TRT. This is used primarily in men undergoing assisted reproduction who are on TRT and cannot stop it, adding FSH helps restore spermatogenesis enough to retrieve sperm for use with in vitro fertilization or intracytoplasmic sperm injection.

The Clinical Conversation That Often Gets Skipped

Men who start TRT without explicit discussion of fertility implications often discover the issue only when they try to conceive. Urologists who specialize in male reproductive health consistently identify this as a common clinical scenario: men who were on TRT for years, discovered they wanted children, and were then told about the suppression they were experiencing.

Any prescribing clinician, whether in a physical clinic or through a telehealth platform, should ask about current and future family planning before initiating TRT. This conversation is a standard-of-care requirement, not an optional add-on.

For context on what TRT involves more broadly, see TRT Side Effects: What the Research Actually Shows. For the signs that initially prompted the TRT consideration, see 9 Signs of Low Testosterone That Men Frequently Dismiss.